One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Journals package 1months
-
http://medilib.ir
- Duration of Time : 31 Day
Price : 100$- Special Price : 50$
Heart Substructure Radiation Dose and Cardiac Outcomes: Contemporary Evidence and Actionable Opportunities: JACC CardioOncology State-of-the-Art Review
doi : 10.1016/j.jaccao.2026.04.009
Volume 8, Issue 3, June 2026, Pages 211-230
Association Between Clonal Hematopoiesis and Cardiometabolic Disease: A Systematic Review and Meta-Analysis
doi : 10.1016/j.jaccao.2026.04.005
Volume 8, Issue 3, June 2026, Pages 231-242
Clonal Hematopoiesis and Cardiometabolic Disease: Expanding Beyond a Hematologic Phenomenon
doi : 10.1016/j.jaccao.2026.05.004
Volume 8, Issue 3, June 2026, Pages 243-244
Immune Profiling Identifies Inflammatory Signatures in Immune Checkpoint Inhibitor–Related Myocarditis
doi : 10.1016/j.jaccao.2026.04.008
Volume 8, Issue 3, June 2026, Pages 245-262
IL-6 in Checkpoint Myocarditis: A Promising Biomarker and Therapeutic Target
doi : 10.1016/j.jaccao.2026.05.003
Volume 8, Issue 3, June 2026, Pages 263-265
Upper Extremity Deep Vein Thrombosis in Cancer Patients: Clinical Course by Cancer Site
doi : 10.1016/j.jaccao.2026.05.008
Volume 8, Issue 3, June 2026, Pages 266-278
Upper-Extremity Deep Vein Thrombosis in Cancer: Beyond a Catheter-Related Complication
doi : 10.1016/j.jaccao.2026.05.007
Volume 8, Issue 3, June 2026, Pages 279-280
A Bleeding Risk Score for Cancer-Associated Venous Thromboembolism in Patients Receiving Direct Oral Anticoagulants
doi : 10.1016/j.jaccao.2026.05.002
Volume 8, Issue 3, June 2026, Pages 281-295
The Future of Bleeding Risk Assessment in Cancer-Associated Thrombosis: The ONCO-DOAC BLEED Score
doi : 10.1016/j.jaccao.2026.05.006
Volume 8, Issue 3, June 2026, Pages 296-298
Differential Transthyretin Stabilization in Patients With Wild Type and Variant Transthyretin Amyloidosis
doi : 10.1016/j.jaccao.2026.04.006
Volume 8, Issue 3, June 2026, Pages 299-313
The Promise and Pitfalls of TTR Stabilization Assays in ATTR-CM
doi : 10.1016/j.jaccao.2026.04.002
Volume 8, Issue 3, June 2026, Pages 314-317
Cardiac Surveillance for Anthracycline Cardiotoxicity: Clinical Yield in Low-to-Intermediate Risk Patients: MATRIX Study
doi : 10.1016/j.jaccao.2026.04.003
Volume 8, Issue 3, June 2026, Pages 318-320
Atrial Fibrillation Risk and Cardiovascular Events After Hematopoietic Cell Transplantation: A Prospective Cohort Study
doi : 10.1016/j.jaccao.2026.04.004
Volume 8, Issue 3, June 2026, Pages 321-323
Treatment and Outcomes in Myocardial Infarction and Cancer—A German Real-Life Analysis
doi : 10.1016/j.jaccao.2026.04.007
Volume 8, Issue 3, June 2026, Pages 324-326
Reframing Mechanistic and Clinical Paradigms of Osimertinib-Associated Cardiotoxicity
doi : 10.1016/j.jaccao.2025.12.011
Volume 8, Issue 3, June 2026, Page 327
REPLY: Reframing Mechanistic and Clinical Paradigms of Osimertinib-Associated Cardiotoxicity
doi : 10.1016/j.jaccao.2026.03.007
Volume 8, Issue 3, June 2026, Page 328
Refining Vascular Biomarker–Guided Risk Stratification for Cancer Therapy–Related Cardiac Dysfunction
doi : 10.1016/j.jaccao.2025.12.012
Volume 8, Issue 3, June 2026, Page 329
REPLY: Refining Vascular Biomarker–Guided Risk Stratification for Cancer Therapy–Related Cardiac Dysfunction
doi : 10.1016/j.jaccao.2026.03.008
Volume 8, Issue 3, June 2026, Pages 330-331
Exploring Overlooked Mediators Linking Myocardial Infarction to Hematologic Malignancies
doi : 10.1016/j.jaccao.2025.08.008
Volume 8, Issue 3, June 2026, Page 332
In Memoriam: Dr Eugene Braunwald, MD, MACC
doi : 10.1016/j.jaccao.2026.05.005
Volume 8, Issue 3, June 2026, Pages 333-334
